Hoshi Y, Matsuda S, Takeuchi M, Kawakubo H, Kitagawa Y
Cancers (Basel). 2025; 17(2).
PMID: 39857978
PMC: 11763614.
DOI: 10.3390/cancers17020196.
Tsui W, Ding S, Jiang P, Lo Y
Genome Res. 2025; 35(1):1-19.
PMID: 39843210
PMC: 11789496.
DOI: 10.1101/gr.278413.123.
Che H, Stanley K, Jatsenko T, Thienpont B, Vermeesch J
Extracell Vesicles Circ Nucl Acids. 2024; 3(3):216-234.
PMID: 39697489
PMC: 11648412.
DOI: 10.20517/evcna.2022.21.
Stewart T, Chalfin H, Simon N, Tan A, Apolo A, McKay R
Bladder Cancer. 2024; 10(3):183-198.
PMID: 39493820
PMC: 11530029.
DOI: 10.3233/BLC-230105.
El-Ahmad P, Mendes-Silva A, Diniz B
Mol Neurobiol. 2024; 62(3):3462-3479.
PMID: 39298102
DOI: 10.1007/s12035-024-04492-y.
Liquid biopsy: paving a new avenue for cancer research.
Kurma K, Eslami-S Z, Alix-Panabieres C, Cayrefourcq L
Cell Adh Migr. 2024; 18(1):1-26.
PMID: 39219215
PMC: 11370957.
DOI: 10.1080/19336918.2024.2395807.
Innovations in Early Lung Cancer Detection: Tracing the Evolution and Advancements in Screening.
Cotton L, Bach P, Cisar C, Schonewolf C, Tennefoss D, Vachani A
J Clin Med. 2024; 13(16).
PMID: 39201053
PMC: 11355097.
DOI: 10.3390/jcm13164911.
Evolving Management of Breast Cancer in the Era of Predictive Biomarkers and Precision Medicine.
Afzal M, Vahdat L
J Pers Med. 2024; 14(7).
PMID: 39063972
PMC: 11278458.
DOI: 10.3390/jpm14070719.
Circulating Liquid Biopsy Biomarkers in Glioblastoma: Advances and Challenges.
Seyhan A
Int J Mol Sci. 2024; 25(14).
PMID: 39063215
PMC: 11277426.
DOI: 10.3390/ijms25147974.
Epigenetics Provides New Perspectives for Diagnosis and Evidence-Based Guidance of Chemotherapy in Cancer.
Santourlidis S, Arauzo-Bravo M, Brodell R, Hassan M, Bendhack M
Int J Mol Sci. 2024; 25(13).
PMID: 39000438
PMC: 11242863.
DOI: 10.3390/ijms25137331.
.
Med Genet. 2024; 34(1):53-68.
PMID: 38836013
PMC: 11110128.
DOI: 10.1515/medgen-2022-2112.
Circulating Tumor DNA as a Complementary Prognostic Biomarker during CAR-T Therapy in B-Cell Non-Hodgkin Lymphomas.
Monick S, Rosenthal A
Cancers (Basel). 2024; 16(10).
PMID: 38791959
PMC: 11120115.
DOI: 10.3390/cancers16101881.
Liquid Biopsies as Non-Invasive Tools for Mutation Profiling in Multiple Myeloma: Application Potential, Challenges, and Opportunities.
Heestermans R, Schots R, De Becker A, Van Riet I
Int J Mol Sci. 2024; 25(10).
PMID: 38791247
PMC: 11121516.
DOI: 10.3390/ijms25105208.
Exploring the Role of Cell-Free Nucleic Acids and Peritoneal Dialysis: A Narrative Review.
Morisi N, Virzi G, Ferrarini M, Alfano G, Zanella M, Ronco C
Genes (Basel). 2024; 15(5).
PMID: 38790182
PMC: 11121405.
DOI: 10.3390/genes15050553.
A brain metastasis liquid biopsy: Where are we now?.
Robinson S, de Boisanger J, Pearl F, Critchley G, Rosenfelder N, Giamas G
Neurooncol Adv. 2024; 6(1):vdae066.
PMID: 38770219
PMC: 11102938.
DOI: 10.1093/noajnl/vdae066.
A Quest for Survival: A Review of the Early Biomarkers of Pancreatic Cancer and the Most Effective Approaches at Present.
Bestari M, Joewono I, Syam A
Biomolecules. 2024; 14(3).
PMID: 38540782
PMC: 10968439.
DOI: 10.3390/biom14030364.
Application of plasma circulating KRAS mutations as a predictive biomarker for targeted treatment of pancreatic cancer.
Lee M, Woo S, Kim M, Han S, Park S, Lee W
Cancer Sci. 2024; 115(4):1283-1295.
PMID: 38348576
PMC: 11007020.
DOI: 10.1111/cas.16104.
Circulating Tumor DNA and Management of Colorectal Cancer.
Krell M, Llera B, Brown Z
Cancers (Basel). 2024; 16(1).
PMID: 38201448
PMC: 10778183.
DOI: 10.3390/cancers16010021.
Clinical applications and perspectives of circulating tumor DNA in gastric cancer.
Li J, Zhang D, Zhu J, Dong L
Cancer Cell Int. 2024; 24(1):13.
PMID: 38184573
PMC: 10770949.
DOI: 10.1186/s12935-024-03209-4.
Circulating tumor DNA: current implementation issues and future challenges for clinical utility.
Hu Q, Chen L, Li K, Liu R, Sun L, Han T
Clin Chem Lab Med. 2023; 62(11):2094-2110.
PMID: 38109307
DOI: 10.1515/cclm-2023-1157.